Prof. Reddy holds B.S. (2003) and M.S. (2004) degrees from Northwestern University (Evanston, IL, USA) in Biomedical Engineering. He completed his Ph.D. thesis at Ecolé Polytechnique Féderale de Lausanne (EPFL) in Bioengineering and Biotechnology in 2008 under the supervision of Prof. Melody Swartz and Prof. Jeffrey Hubbell; his research was centered on developing a novel nanoparticle vaccine technology, of which he was awarded KPMG tomorrow’s market award in 2007. Prof. Reddy moved to University of Texas, Austin (USA) under the supervision of Prof. George Georgiou for his post-?doctoral fellowship (2008), where he worked on protein and antibody engineering. His work was exemplified by a technology he co-?developed on monoclonal antibody discovery without screening, which combined high-?throughput DNA sequencing, bioinformatics, and synthetic biology and importantly, demonstrated how systems and synthetic immunology can impact biotechnology.
Market Data 
Markets 
AI
